These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 2783211)

  • 1. Candidate biomarkers in psychiatric disorders: state of the field.
    Abi-Dargham A; Moeller SJ; Ali F; DeLorenzo C; Domschke K; Horga G; Jutla A; Kotov R; Paulus MP; Rubio JM; Sanacora G; Veenstra-VanderWeele J; Krystal JH
    World Psychiatry; 2023 Jun; 22(2):236-262. PubMed ID: 37159365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer.
    Lu X; Liu R; Wang M; Kumar AK; Pan F; He L; Hu Z; Guo Z
    Oncogene; 2020 Jan; 39(1):234-247. PubMed ID: 31471584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A polymorphism in the norepinephrine transporter gene is associated with affective and cardiovascular disease through a microRNA mechanism.
    Marques FZ; Eikelis N; Bayles RG; Lambert EA; Straznicky NE; Hering D; Esler MD; Head GA; Barton DA; Schlaich MP; Lambert GW
    Mol Psychiatry; 2017 Jan; 22(1):134-141. PubMed ID: 27046647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise and bipolar disorder: a review of neurobiological mediators.
    Alsuwaidan MT; Kucyi A; Law CW; McIntyre RS
    Neuromolecular Med; 2009; 11(4):328-36. PubMed ID: 19649751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced norepinephrine output during long-term desipramine treatment: a possible role for the extraneuronal monoamine transporter (SLC22A3).
    Mooney JJ; Samson JA; Hennen J; Pappalardo K; McHale N; Alpert J; Koutsos M; Schildkraut JJ
    J Psychiatr Res; 2008 Jul; 42(8):605-11. PubMed ID: 17727882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modest neuropsychological deficits caused by reduced noradrenaline metabolism in mice heterozygous for a mutated tyrosine hydroxylase gene.
    Kobayashi K; Noda Y; Matsushita N; Nishii K; Sawada H; Nagatsu T; Nakahara D; Fukabori R; Yasoshima Y; Yamamoto T; Miura M; Kano M; Mamiya T; Miyamoto Y; Nabeshima T
    J Neurosci; 2000 Mar; 20(6):2418-26. PubMed ID: 10704516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular calcium signalling in peripheral cells of patients with bipolar affective disorder.
    Dubovsky SL; Thomas M; Hijazi A; Murphy J
    Eur Arch Psychiatry Clin Neurosci; 1994; 243(5):229-34. PubMed ID: 8172936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine activity reflected in urine of young patients with obsessive compulsive disorder, psychosis with and without reality distortion and healthy subjects: an explorative analysis.
    Oades RD; Röpcke B; Eggers C
    J Neural Transm Gen Sect; 1994; 96(2):143-59. PubMed ID: 7857597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHPG excretion by patients with affective disorders.
    Maas JW; Dekirmenjian H; Fawcett JA
    Int Pharmacopsychiatry; 1974; 9(1):14-26. PubMed ID: 4600126
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and biochemical heterogeneity of depressive disorders.
    Maas JW
    Ann Intern Med; 1978 Apr; 88(4):556-63. PubMed ID: 25035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward a biochemical classification of depressive disorders. X. Urinary catecholamines, their metabolites, and D-type scores in subgroups of depressive disorders.
    Schatzberg AF; Samson JA; Bloomingdale KL; Orsulak PJ; Gerson B; Kizuka PP; Cole JO; Schildkraut JJ
    Arch Gen Psychiatry; 1989 Mar; 46(3):260-8. PubMed ID: 2783211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward a biochemical classification of depressive disorders. II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites.
    Schildkraut JJ; Orsulak PJ; LaBrie RA; Schatzberg AF; Gudeman JE; Cole JO; Rohde WA
    Arch Gen Psychiatry; 1978 Dec; 35(12):1436-9. PubMed ID: 727879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.
    Schildkraut JJ; Orsulak PJ; Schatzberg AF; Gudeman JE; Cole JO; Rohde WA; LaBrie RA
    Arch Gen Psychiatry; 1978 Dec; 35(12):1427-33. PubMed ID: 727878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward a biochemical classification of depressive disorders, V: Heterogeneity of unipolar depressions.
    Schatzberg AF; Orsulak PJ; Rosenbaum AH; Maruta T; Kruger ER; Cole JO; Schildkraut JJ
    Am J Psychiatry; 1982 Apr; 139(4):471-5. PubMed ID: 7065292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catecholamine measures for diagnosis and treatment of patients with depressive disorders.
    Schatzberg AF; Orsulak PJ; Rosenbaum AH; Kruger ER; Schildkraut JJ; Cole JO
    J Clin Psychiatry; 1980 Dec; 41(12 Pt 2):35-9. PubMed ID: 7440524
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.